Articles tagged with Ophthalmology
A researcher at the University of Minnesota Medical School has been awarded a $3.7 million NIH grant to develop robust AI models for primary open-angle glaucoma prognosis. The project aims to improve patient outcomes by identifying patients at high risk of vision loss earlier and more accurately.
Researchers at Technion-Israel Institute of Technology discovered that mature, aged cells can revert into active stem cells that regenerate damaged tissue. This finding challenges the prevailing view on tissue regeneration and implies the possibility of therapies promoting natural healing mechanisms.
A study from Linköping University finds that mild COVID-19 can lead to long-term eye problems, including abnormal pupil function and strabismus, affecting daily life. Researchers developed a diagnostic model to detect these issues, which may lead to effective treatment.
Healome Therapeutics has secured £2m in funding to develop an eye drop technology that combines drug retention, lubrication, and protection. The platform aims to reduce dosing regimens and improve patient outcomes for diseases affecting the surface of the eye, including dry eye disease and rare ocular surface conditions.
A comprehensive review examines global trends in antimicrobial resistance in animal eye infections, warning that multidrug-resistant bacteria are becoming more common. The authors call for earlier diagnostic testing, targeted antibiotic use, and stronger infection-control measures to preserve treatment options.
A new study published in Eye and Vision finds that one drop of low-dose atropine can produce daylong effects in managing myopia. The researchers found that the drop showed clear changes in pupil size and focusing ability, but no short-term structural effects on the eye.
A team of scientists at the University of California, Davis, has discovered an inherited form of blindness directly comparable to autosomal dominant optic atrophy (ADOA) in rhesus macaques. The study could lead to a better understanding of ADOA and potentially new treatments.
A Tohoku University research group developed an AI model that estimates retinal age from a fundus photograph, reflecting biological aging and potential disease risk. The model is non-invasive and can be used as a screening aid, identifying patients who may need further health assessments.
Mount Sinai ophthalmologist has developed a groundbreaking device enabling precise measurement of aqueous outflow during eye surgery. The technology offers improved accuracy and reduced complications, potentially transforming the field of ophthalmology.
Researchers at Terasaki Institute for Biomedical Innovation develop a smart contact lens that monitors intraocular pressure in real time and delivers treatment. The technology has shown promising results in preclinical models and aims to improve quality of life for patients with ocular diseases.
A new AI-driven test, PROMinsight, captures patients' quality of life in minutes, helping doctors make faster, better-informed decisions. The test is tailored for various eye conditions and translates insights into precise data that informs both care and research.
A new portable AI-powered scanning slit-light device makes low-cost eye disease screening more accessible, providing quantitative measurements and qualitative assessments of anterior-segment abnormalities. The lightweight AI model allows for on-device analysis, reducing operator dependence and improving portability.
A new AI chatbot helps patients access retinal detachment advice through personalized, real-time, clinically grounded conversations. The system outperformed leading large language models and includes accessibility features for people with low vision or limited English proficiency.
Researchers at Osaka Metropolitan University identified the tegmentum region as the area where light signals from the eyes and pineal organ are integrated. This integration enables fish to swim up or down based on differences in light wavelength, aiding survival decisions.
A retrospective cohort study in primary care found that patients with floaters or flashes have a higher risk of retinal detachment. The study, published in the Annals of Family Medicine, analyzed data from 1,181 episodes and found that new or recently changed acute floaters were associated with a higher relative risk.
Analysis of unintended side effect reports reveals that Wegovy carries the highest risk of 'eye stroke' and sudden sight loss among semaglutide drugs, with odds nearly 5 times higher than Ozempic. The risk is particularly pronounced in men, with a signal nearly 3 times higher than in women.
Researchers at the University of Pittsburgh School of Medicine develop an experimental 'living eye drop' using naturally occurring eye bacteria to accelerate corneal wound healing. The engineered bacteria, Corynebacterium mastitidis, continuously secrete interleukin-10, a protein that regulates inflammation.
A University of Houston optometry researcher warns of the dangers of red-light laser myopia therapy for children, citing vision damage reports and the need for rigorous safety validation. The professor's quality improvement study found that two popular devices exceeded national standards for safety classifications.
Researchers found that veterans with prior concussions showed slower and less accurate eye movements, along with reduced performance on attention-based tasks. These subtle brain changes can be measured more than a decade after the original injury.
Pickleball professionals and amateurs showed low use of high-quality protective eyewear, with many relying on personal prescription glasses that may not provide adequate protection. This study underscores the importance of consistent use of well-fitting protective eyewear to prevent pickleball-related eye injuries.
A nationwide cohort study found that semaglutide initiators had a significantly higher risk of developing nonarteritic anterior ischemic optic neuropathy compared to sodium-glucose cotransporter-2 inhibitor initiators. The absolute risk was low, but clinicians and patients should be aware of this rare but evident increased risk.
A large-scale study found that patients taking tirzepatide had a significantly lower risk of developing new diabetic retinopathy or progressing to more severe stages. This suggests that the medication may not worsen eye health, offering relief for patients concerned about their vision.
Researchers found metformin reduces progression of AMD by 37% in people over 55 years, a breakthrough in search for new treatments. The study used pictures from 2,000 eye screenings and adjusted for factors like age, sex, and duration of diabetes.
Researchers at Waseda University have developed an integrated smart contact lens that enables real-time intraocular pressure monitoring for early glaucoma diagnosis. The device leverages parity-time symmetry for ultra-sensitive wireless detection, increasing sensitivity by a factor of 183.
Researchers used MRI analysis to measure glymphatic system activity, finding changes related to IIH stage and pressure levels. The findings suggest a noninvasive test could diagnose IIH more reliably, improving treatment options for patients with symptoms including headaches and vision loss.
A study by Stanford Medicine researchers found that people with colorblindness have a 52% higher mortality rate over 20 years compared to those with normal vision due to delayed diagnosis. The study suggests that missing the early sign of blood in urine can lead to worse outcomes.
A new study estimates that over 1.6 million people in the UK will be living with glaucoma by 2060, with nearly 50% higher prevalence than previous estimates. The researchers call for expanded eye health services and increased awareness campaigns to detect early cases and prevent vision loss.
A new study demonstrates the effectiveness of a widely-used eye injection in managing hypotony, a rare condition characterized by abnormally low eye pressure. The treatment, which involves injecting HPMC gel, has shown promising results in restoring vision and increasing eye pressure.
Researchers identified changes in RNA molecules involved in cell's splicing machinery, causing retinitis pigmentosa in ~30-40% of patients with genetic disorder. Variants in five non-coding RNA genes were found to be responsible for the disease, offering a new diagnostic pathway for families worldwide.
A novel clinical trial is exploring if a stem cell-derived retinal implant can not only stop the progression of dry age-related macular degeneration but also improve patients' vision. The implant uses lab-engineered RPE cells to replace damaged cells in the retina, potentially restoring central vision.
NEJM Clinician curates highly relevant clinical insights from over 150 peer-reviewed journals to give physicians clear guidance without the noise. The weekly publication delivers summaries and commentary in a concise, 30-minute read, helping healthcare providers stay informed and confident in their decisions.
Researchers developed a revolutionary AI platform to assess the fairness and accuracy of commercial algorithms in detecting diabetic eye disease. The platform was tested on 1.2 million images from diverse ethnic groups, achieving high accuracy rates compared to human grading.
Optic disc edema progression in spaceflight predicted using optical coherence tomography imaging, suggesting crew members without ODE on day 30 unlikely to develop concern on day 150. This technology offers opportunity for predicting ODE magnitude during longer missions.
A new MIT study reveals that temporarily anesthetizing the retina of the amblyopic eye can restore its neural connections and improve vision in adulthood. The treatment, which has been shown to be effective in infancy and early childhood, may have promising clinical potential for adults with amblyopia.
The INSIGHT Health Data Research Hub for Eye Health and Oculomics is expanding UK eye health research by linking national data resources, supporting research and improving patient care. The hub will on-board NHS sites, broaden national data linkages, and integrate genetic data to accelerate oculomics research.
A new tool, WatDAT, measures vision equally precisely in younger toddlers by asking them to point out different shapes at progressively smaller sizes. This test can lead to earlier detection and treatment of vision problems in children under three, such as amblyopia or farsightedness.
A cohort study found that GLP-1 receptor agonist use was associated with a reduced risk of developing nonexudative AMD, but not progression to exudative AMD in individuals with nonexudative AMD. This study may inform future randomized trials evaluating the ocular effects of GLP-1RAs in nondiabetic populations.
A pioneering eye device has restored reading vision to people with sight loss, allowing them to read letters, numbers, and words through a prosthetic eye. The PRIMA chip operation involves an implant paired with augmented-reality glasses, enabling patients to regain their independence and confidence.
A wireless retinal implant has been shown to restore central vision in patients with advanced age-related macular degeneration (AMD), with 81% of participants achieving clinically meaningful improvements in visual acuity. The device converted light into electrical signals, stimulating remaining retinal cells and restoring visual inform...
Dr. Kathryn Colby, NYU Langone Health's chair of ophthalmology, has received the prestigious Castroviejo Medal for her pioneering work on Fuchs endothelial corneal dystrophy. Her research explores a new surgical procedure to stimulate corneal regeneration.
The study found that 1-year DMEK success rates were high regardless of donor diabetes status. No restrictions on using tissue from donors with diabetes for DMEK are recommended based on the results.
A randomized clinical trial showed that DMEK graft success is comparable between diabetes-positive and non-diabetes donor corneas after 1 year. The study's findings support the use of diabetes-positive donor corneas for endothelial keratoplasty procedures.
A significant increase in pickleball-related ocular injuries has been reported among patients presenting to emergency departments. Eye protection guidelines are not currently in place, highlighting the need for standardized measures to reduce the risk of such injuries.
Exposure to lower levels of air pollutants is associated with improved vision in children, suggesting that reducing exposure could slow the progression of myopia. Children who live in areas with cleaner air have better vision, especially younger students.
Researchers are testing whether low-concentrate atropine drops can delay the onset of myopia in children. The study aims to reduce the risk of sight-threatening complications later in life by decreasing how nearsighted someone becomes.
A new study shows that laser treatment, PRK, is as safe and effective in treating myopia in older teenagers (17-18 years) as it is in adults. The procedure achieved excellent results with around 64% of teenagers' eyes achieving 20/20 vision.
Patients who had cataract surgery or received a new type of lens for presbyopia correction have excellent vision over near, intermediate, and far distances without glasses. The study found that nearly all patients needed glasses 'none' or 'a little of the time' for distance and intermediate vision.
Researchers developed a new treatment using specially formulated eye drops that improved near vision for patients with presbyopia. The study found that the majority of patients could read extra lines on the Jaeger chart after using the eye drops, and improvements were sustained for up to two years.
A study found that more than half of the general population in the USA and Europe experience dry eyes, with only 20% of European patients and 17% of US patients receiving a diagnosis. The delay in seeking treatment is concerning, as early intervention can prevent inflammation and worsening symptoms.
Researchers used AI to assess images of patients' eyes and predict those who needed prompt treatment, successfully sorting up to 90% of patients. The study's findings could lead to earlier treatment and reduced unnecessary monitoring for patients with keratoconus.
Two new studies show that cataract surgery on both eyes can be safe and effective for most patients to perform immediately after surgery, with high rates of independence and minimal need for assistance. Patients receiving multifocal lenses achieved the best visual outcomes, with over 85% achieving 20/20 vision or better.
The Global RETFound initiative aims to develop the world's first globally representative AI foundation model in medicine, addressing health inequalities and AI bias. The project involves a diverse dataset of over 100 million fundus photographs sourced from 65+ countries.
Researchers from Osaka Metropolitan University discovered a novel light-sensing mechanism in reef-building corals, where opsins use chloride ions as counterions to detect visible light. This unique functionality suggests that coral light sensitivity can adjust according to the algae's photosynthetic activity.
Researchers at Wayne State University are developing novel therapies to treat ocular chemical injuries using host-derived metabolites. The project aims to reduce inflammation, promote corneal nerve regeneration, and enhance wound healing, with potential for clinically translatable treatments that can preserve vision.
Kanishka Thiran Jayasundera has been appointed professor and chair of the Department of Ophthalmology and Vision Science at UC Davis Health. He is recognized for his research on retinal diseases and integrating mental health support with eye care.
Researchers have created an alternative to LASIK surgery by remodeling the cornea through electromechanical reshaping (EMR), a process that uses electric potentials to alter the tissue's pH, making it malleable. The new technique has shown promising results in improving vision and could potentially be reversed or used for other vision ...
A study found no association between semaglutide treatment and diabetic retinopathy, but suggested a potential link to nonarteritic anterior ischemic optic neuropathy. Further research with larger sample sizes is needed to clarify this risk.
Cohort study finds GLP-1 receptor agonist use associated with modestly increased risk of incident diabetic retinopathy; however, those with preexisting DR experience fewer sight-threatening complications. Regular screening and monitoring recommended for all T2D patients on GLP-1 RAs.
A UCLA team has uncovered new details about the muscle controlling blinking, offering a pathway toward developing blink-assisting prostheses. The orbicularis oculi muscle contracts in complex patterns that vary by action and move the eyelid in more than just a simple up-and-down motion.
A study found that semaglutide and liraglutide use are associated with a higher risk of nonarteritic anterior ischemic optic neuropathy in older patients with type 2 diabetes. The GLP-1 receptor agonists showed varying levels of risk, with liraglutide posing the greatest threat.